• ABOUT
  • TEAM
  • SERVICES
  • RESULTS
  • MEDIA & EVENTS

Plexus Ventures Advises YouMedical B.V. (Netherlands) on Sale to Trimb Healthcare AB (Sweden)

by plexusventures_h3tnl0 | Aug 31, 2015 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce it served as advisor to YouMedical BV shareholders in the company’s sale to Trimb Healthcare. Signing occurred on August 27, 2015, with completion expected during September. Plexus Ventures’...

Plexus Ventures Assists Celon Pharma to Out-License Certain Rights of Generic Advair® Diskus® to Lupin Limited for the U.S., Mexico, South Africa and Australia

by plexusventures_h3tnl0 | Mar 20, 2015 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures announces the successful completion of a recent out-licensing project on behalf of Celon Pharma. Additional details regarding the transaction, taken from Lupin Limited’s February 17, 2015 press release are included...

Plexus Ventures Completes Successful Divestment and Out-Licensing Projects

by plexusventures_h3tnl0 | Jan 16, 2015 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures announces the successful completion of two important partnering projects: ONE MORE SUCCESSFUL DIVESTMENT OF MATURE PRODUCTS Plexus provided professional services to Reckitt Benckiser (www.rb.com) in their divestment...

Plexus Ventures Assists Novartis with 10th Successful Product Divestment

by plexusventures_h3tnl0 | Jan 9, 2015 | Uncategorized

Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce the successful completion of its 10th product divestment for Novartis AG. Plexus provided professional services to Novartis Consumer Health, Inc. in the divestiture of U.S. commercial rights to...
« Older Entries
Next Entries »

Recent Posts

  • Plexus Ventures Assists First Pharma in Successful Completion of Business Sale to a Strategic Buyer
  • Plexus Ventures Assists Sanofi Consumer Health to Divest a Product Portfolio in Australia and South-East Asia to Phoenix Labs
  • Plexus Ventures Assists Elthera AG in the Licensing of its First-in-Class Antibody
  • Celon Pharma enters agreement with Zydus Lifesciences Ltd.
  • Mindpax engages Plexus Ventures as Exclusive Advisor to Partner its Digital Platform for Severe Mental Illnesses

Recent Comments

    Collaborating with clients to grow their businesses; committing our experience, resources and time to their success.

    Business Builders in Healthcare

    Contact Us
    • Follow

    About Us

    Our Team

    Areas of Expertise

    Project Portfolio

    What’s Trending